Boxer Capital Management’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
Other funds holding MDGL
BBA
Boxer Capital Management's MDGL Position: Q4 2023 in Review
Boxer Capital Management sold out of Madrigal Pharmaceuticals (MDGL) in Q4 2023, closing a stake of 100,000 shares — an estimated $14.6M sold.
Boxer Capital Management first reported a position in MDGL in Q2 2018 and held it in 3 quarters. The position peaked at $26.6M in Q2 2018. 226 funds tracked by Wall St. Rank hold MDGL as of Q4 2023.
- Boxer Capital Management reported no remaining Madrigal Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
- Boxer Capital Management sold 100,000 Madrigal Pharmaceuticals shares in Q4 2023, an estimated $14.6M.
- Boxer Capital Management first reported a position in Madrigal Pharmaceuticals in Q2 2018 and held it in 3 quarters.
- Boxer Capital Management's Madrigal Pharmaceuticals position peaked at $26.6M in Q2 2018.
- 226 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q4 2023.
Based on Boxer Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.